ESRP1 and neoplasm: Coherently with the analysis of clinical data in relation to the ESRP1 and ESPR2 expression, most of the 27 ASEs were significantly related (p < 0.05) to the tumor molecular subtype (22 events), the fraction of altered genome (20 events), the menopause status, and the diagnosis age (8 events) (Supplementary Materials Table S8f).